Decision - re Patent Owner's Motion to Preserve Record | Oct 19, 2017 | PAPER | BOARD |
Patent Owner's Notice of Appeal | Jul 31, 2017 | PAPER | PATENT OWNER |
Patent Owner's Motion For Preservation Of The Record Pending Appeal And Motion To Expunge Confidential Information Under 37 C.F.R. 42.56 | Jul 28, 2017 | PAPER | PATENT OWNER |
Final Written Decision | Jul 6, 2017 | PAPER | BOARD |
Record of Oral Hearing | May 12, 2017 | PAPER | BOARD |
AbbVie's Demonstrative Exhibits | Mar 30, 2017 | PAPER | PATENT OWNER |
Petitioner's Demonstrative Exhibits | Mar 30, 2017 | PAPER | PETITIONER |
Hearing Order | Mar 24, 2017 | PAPER | BOARD |
Patent Owner's Request for Oral Argument | Mar 10, 2017 | PAPER | PATENT OWNER |
Petitioner's Request for Oral Argument | Mar 10, 2017 | PAPER | PETITIONER |
Patent Owner's Objections to Evidence | Feb 24, 2017 | PAPER | PATENT OWNER |
CV of Michael H. Weisman, M.D. | Feb 16, 2017 | EXHIBIT | PETITIONER |
Harvey Dep. Tr. | Feb 16, 2017 | EXHIBIT | PETITIONER |
Gibofsky Dep. Tr. | Feb 16, 2017 | EXHIBIT | PETITIONER |
Allan Gibofsky 2013 Payments | Feb 16, 2017 | EXHIBIT | PETITIONER |
Allan Gibofsky 2014 Payments | Feb 16, 2017 | EXHIBIT | PETITIONER |
Allan Gibofsky 2013 Report | Feb 16, 2017 | EXHIBIT | PETITIONER |
Allan Gibofsky 2014 Report | Feb 16, 2017 | EXHIBIT | PETITIONER |
Allan Gibofsky 2015 Report | Feb 16, 2017 | EXHIBIT | PETITIONER |
Vinks Dep. Tr. From IPR2016-00172 | Feb 16, 2017 | EXHIBIT | PETITIONER |
Vinks Marked-up Version of Excerpts from Clinical Pharmacokinetics Concepts and Applications | Feb 16, 2017 | EXHIBIT | PETITIONER |
Cambridge Antibody Technology Group Press Release from November 9, 1998 | Feb 16, 2017 | EXHIBIT | PETITIONER |
REMICADE Label (December 2000) | Feb 16, 2017 | EXHIBIT | PETITIONER |
CV of Dr. William J. Jusko, Ph.D. | Feb 16, 2017 | EXHIBIT | PETITIONER |
Hausman Dep. Tr. | Feb 16, 2017 | EXHIBIT | PETITIONER |
Sailstad Dep. Tr. | Feb 16, 2017 | EXHIBIT | PETITIONER |
Vinks Dep. Tr. | Feb 16, 2017 | EXHIBIT | PETITIONER |
Gibofsky Webpage | Feb 16, 2017 | EXHIBIT | PETITIONER |
Allan Gibofsky 2015 Payments | Feb 16, 2017 | EXHIBIT | PETITIONER |
USPTO Letter re Patent Term Extension Certificate | Feb 16, 2017 | EXHIBIT | PETITIONER |
Vinks, Chapter 3 from Pediatric Psychopharmacology | Feb 16, 2017 | EXHIBIT | PETITIONER |
BASF, The Pharma Letter from June 23, 2000 | Feb 16, 2017 | EXHIBIT | PETITIONER |
Rau 1999, Rheumatol., Vol. 58 (Suppl. 1) 1/41. P2 (1999) | Feb 16, 2017 | EXHIBIT | PETITIONER |
Petitioner's Updated Exhibit List | Feb 16, 2017 | PAPER | PETITIONER |
Petitioner's Reply to Patent Owner's Response | Feb 16, 2017 | PAPER | PETITIONER |
Patent Owner's Third Updated Mandatory Notices | Feb 10, 2017 | PAPER | PATENT OWNER |
Notice of Joint Stipulation to Modify Due Dates 2, 4 and 5 | Jan 23, 2017 | PAPER | PETITIONER |
Petitioner's Updated Mandatory Notices | Jan 3, 2017 | PAPER | PETITIONER |
Petitioner's Notice of Deposition of Dr. Allan Gibofsky | Dec 19, 2016 | PAPER | PETITIONER |
Petitioner's Notice of Deposition of Jeffrey M. Sailstad | Dec 19, 2016 | PAPER | PETITIONER |
Petitioner's Notice of Deposition of Dr. Alexander A. Vinks | Dec 19, 2016 | PAPER | PETITIONER |
Petitioner's Notice of Deposition of Dr. Brian E. Harvey | Dec 19, 2016 | PAPER | PETITIONER |
Petitioner's Notice of Deposition of Dr. Jerry A. Hausman | Dec 19, 2016 | PAPER | PETITIONER |
Notices of Joint Stipulation to Modify Due Dates 2 and 4 | Dec 16, 2016 | PAPER | PETITIONER |
Petitioner's Objections to Patent Owner's Exhibits | Nov 4, 2016 | PAPER | PETITIONER |
Patent Owner's Motion to Seal Under 37 C.F.R. Sec. 42.54 | Oct 28, 2016 | PAPER | PATENT OWNER |
Patent Owner's Updated Exhibit List | Oct 28, 2016 | PAPER | PATENT OWNER |
Mager & Jusko (2002) | Oct 28, 2016 | EXHIBIT | PATENT OWNER |
Lon (2013) | Oct 28, 2016 | EXHIBIT | PATENT OWNER |
US 2007/0275063 A1 | Oct 28, 2016 | EXHIBIT | PATENT OWNER |
Amendment and Petition for Extension of Time | Oct 28, 2016 | EXHIBIT | PATENT OWNER |
Maini (1999) | Oct 28, 2016 | EXHIBIT | PATENT OWNER |
Ianculescu & Weisman (2016) | Oct 28, 2016 | EXHIBIT | PATENT OWNER |
Weisman (1997) | Oct 28, 2016 | EXHIBIT | PATENT OWNER |
Smolen (2007) | Oct 28, 2016 | EXHIBIT | PATENT OWNER |
Wolfe (2001) | Oct 28, 2016 | EXHIBIT | PATENT OWNER |
Smolen (2000) | Oct 28, 2016 | EXHIBIT | PATENT OWNER |
Furst (May 2000) | Oct 28, 2016 | EXHIBIT | PATENT OWNER |
Furst (May 2002) | Oct 28, 2016 | EXHIBIT | PATENT OWNER |
Patent Owner's Response | Oct 28, 2016 | PAPER | PATENT OWNER |
Notices of Deposition of William Jusko | Oct 28, 2016 | EXHIBIT | PATENT OWNER |
Jusko (Feb. 22, 2013) | Oct 28, 2016 | EXHIBIT | PATENT OWNER |
Cao (2013) | Oct 28, 2016 | EXHIBIT | PATENT OWNER |
Woo & Jusko (2007) | Oct 28, 2016 | EXHIBIT | PATENT OWNER |
DeVane & Jusko (1982) | Oct 28, 2016 | EXHIBIT | PATENT OWNER |
Furst et al. (May 2003) | Oct 28, 2016 | EXHIBIT | PATENT OWNER |
Notice of Deposition of Michael Weisman | Oct 28, 2016 | EXHIBIT | PATENT OWNER |
Barnett (1998) | Oct 28, 2016 | EXHIBIT | PATENT OWNER |
Furst (2003) | Oct 28, 2016 | EXHIBIT | PATENT OWNER |
Paulus (2000) | Oct 28, 2016 | EXHIBIT | PATENT OWNER |
Transcript of Deposition of William Jusko (Sep. 30, 2016) | Oct 28, 2016 | EXHIBIT | PATENT OWNER |
Declaration of Dr. Brian Harvey | Oct 28, 2016 | EXHIBIT | PATENT OWNER |
Declaration of Dr. Jerry A. Hausman (PROTECTIVE ORDER MATERIAL) | Oct 28, 2016 | EXHIBIT | PATENT OWNER |
Declaration of Dr. Alexander A. Vinks | Oct 28, 2016 | EXHIBIT | PATENT OWNER |
van de Putte 2000 (Blowup of Ex. 1009) | Oct 28, 2016 | EXHIBIT | PATENT OWNER |
Karlsson, BR. J. CLIN. PHARMACOL. (1998) | Oct 28, 2016 | EXHIBIT | PATENT OWNER |
Sacks, JAMA (2014) | Oct 28, 2016 | EXHIBIT | PATENT OWNER |
Mevorach & Paget (2000) | Oct 28, 2016 | EXHIBIT | PATENT OWNER |
Gibofsky, CURRENT MED. RES. & OP.(2006) | Oct 28, 2016 | EXHIBIT | PATENT OWNER |
van de Putte 2000 | Oct 28, 2016 | EXHIBIT | PATENT OWNER |
Sedger & McDermott, CYTOKINE & GROWTH FACTOR REVIEWS (2014) | Oct 28, 2016 | EXHIBIT | PATENT OWNER |
Moreland, ARTHRITIS & RHEUMATISM (1997) | Oct 28, 2016 | EXHIBIT | PATENT OWNER |
van de Putte 1 Yr Efficacy Results | Oct 28, 2016 | EXHIBIT | PATENT OWNER |
Furst (2013) | Oct 28, 2016 | EXHIBIT | PATENT OWNER |
Transcript of Deposition of Michael Weisman (Oct. 10, 2016) | Oct 28, 2016 | EXHIBIT | PATENT OWNER |
Declaration of Dr. Allan Gibofsky | Oct 28, 2016 | EXHIBIT | PATENT OWNER |
Declaration of Dr. Jerry A. Hausman (REDACTED VERSION) | Oct 28, 2016 | EXHIBIT | PATENT OWNER |
Declaration of Jeffrey M. Sailstad | Oct 28, 2016 | EXHIBIT | PATENT OWNER |
Mordenti, TOXICOLOGIC PATHOLOGY (1999) | Oct 28, 2016 | EXHIBIT | PATENT OWNER |
WO98/004281 | Oct 28, 2016 | EXHIBIT | PATENT OWNER |
Rau (1999) | Oct 28, 2016 | EXHIBIT | PATENT OWNER |
Weinblatt, TRANSACTIONS OF THE AM. CLIN. & CLIMATOLOGICAL ASS'n (2013) | Oct 28, 2016 | EXHIBIT | PATENT OWNER |
Rowland & Tozer (2011) | Oct 28, 2016 | EXHIBIT | PATENT OWNER |
MW\PHARM Ver. 3.15, Vols. 1-3 | Oct 28, 2016 | EXHIBIT | PATENT OWNER |
Points to Consider (Feb. 28, 1997) | Oct 28, 2016 | EXHIBIT | PATENT OWNER |
Miller, PHARMACEUTICAL RESEARCH (2001) | Oct 28, 2016 | EXHIBIT | PATENT OWNER |
Mire-Sluis, J. IMMUNOLOGICAL METHODS (2004) | Oct 28, 2016 | EXHIBIT | PATENT OWNER |
Kress (Dec. 24, 2002) | Oct 28, 2016 | EXHIBIT | PATENT OWNER |
Stephens, IMMUNOLOGY (1995) | Oct 28, 2016 | EXHIBIT | PATENT OWNER |
Smolen, ANN. RHEUM. DIS. (2013) | Oct 28, 2016 | EXHIBIT | PATENT OWNER |
Rowland & Tozer (1995) | Oct 28, 2016 | EXHIBIT | PATENT OWNER |
Prevoo, ARTHRITIS & RHEUMATISM (1995) | Oct 28, 2016 | EXHIBIT | PATENT OWNER |
Weaver, CURRENT MED. RES. & OP. (2006) | Oct 28, 2016 | EXHIBIT | PATENT OWNER |
MwPharm ver. 3.82 (update of ver. 3.60) (Feb. 16, 2014) | Oct 28, 2016 | EXHIBIT | PATENT OWNER |
Neef & Vinks, PHARMACEUTISCH WEEKBLAD (2000) (Dutch Original) | Oct 28, 2016 | EXHIBIT | PATENT OWNER |
Neef & Vinks, PHARMACEUTICS WEEKLY (2000) (English Translation) | Oct 28, 2016 | EXHIBIT | PATENT OWNER |
Etanercept-ENBREL¿¿ label (1998) | Oct 28, 2016 | EXHIBIT | PATENT OWNER |
The Lenercept MS Study Group, NEUROLOGY (1999) | Oct 28, 2016 | EXHIBIT | PATENT OWNER |
Feldmann & Maini, ANNU. REV. IMMUNOL. (2001) | Oct 28, 2016 | EXHIBIT | PATENT OWNER |
Findlay, J. PHARM. BIOMED. ANAL. (2000) | Oct 28, 2016 | EXHIBIT | PATENT OWNER |
Kavanaugh, RHEUMATIC DISEASE CLINICS OF N. AM. (1998) | Oct 28, 2016 | EXHIBIT | PATENT OWNER |
Clark, IMMUNOLOGY TODAY (2000) | Oct 28, 2016 | EXHIBIT | PATENT OWNER |
Curriculum Vitae of Jeff Sailstad | Oct 28, 2016 | EXHIBIT | PATENT OWNER |
Proudfoot (2002) | Oct 28, 2016 | EXHIBIT | PATENT OWNER |
Taylor, ARTHRITIS & RHEUMATISM (2000) | Oct 28, 2016 | EXHIBIT | PATENT OWNER |
Maini & Feldmann, ARTHRITIS RES. (2002) | Oct 28, 2016 | EXHIBIT | PATENT OWNER |
Sailstad, THE AAPS JOURNAL (2014) | Oct 28, 2016 | EXHIBIT | PATENT OWNER |
Curriculum Vitae of Dr. Alexander A. Vinks | Oct 28, 2016 | EXHIBIT | PATENT OWNER |
van de Putte et al. (2004) | Oct 28, 2016 | EXHIBIT | PATENT OWNER |
Ross, ANN. NEUROL. (2000) | Oct 28, 2016 | EXHIBIT | PATENT OWNER |
O¿¿¿Dell, ANN. RHEUM. DIS. (1996) | Oct 28, 2016 | EXHIBIT | PATENT OWNER |
Rossert, J. AM. SOC. NEPHROL. (2004) | Oct 28, 2016 | EXHIBIT | PATENT OWNER |
DiMasi, J. HEALTH ECON. (2003) | Oct 28, 2016 | EXHIBIT | PATENT OWNER |
Genovese, ANN RHEUM DIS (2013) | Oct 28, 2016 | EXHIBIT | PATENT OWNER |
Approval Letter, Adalimumab (HUMIRA) (Dec. 31, 2002) | Oct 28, 2016 | EXHIBIT | PATENT OWNER |
Adalimumab (HUMIRA)Package Insert (Dec. 2002) | Oct 28, 2016 | EXHIBIT | PATENT OWNER |
Eckardt & Casadevall, NEPHROL. DIAL. TRANSPLANT. (2003) | Oct 28, 2016 | EXHIBIT | PATENT OWNER |
Sander & Rau, INT¿¿¿L J. CLIN. PHARM. THERAPEUTICS (1998) | Oct 28, 2016 | EXHIBIT | PATENT OWNER |
Khan (2002) | Oct 28, 2016 | EXHIBIT | PATENT OWNER |
ClinicalTrials.gov identifier NCT00077870 | Oct 28, 2016 | EXHIBIT | PATENT OWNER |
O'Dell (2002) | Oct 28, 2016 | EXHIBIT | PATENT OWNER |
Ruderman & Tambar, Rheumatoid Arthritis | Oct 28, 2016 | EXHIBIT | PATENT OWNER |
Furst, Arthritis & Rheumatism (1996) | Oct 28, 2016 | EXHIBIT | PATENT OWNER |
Hasler, (1996) | Oct 28, 2016 | EXHIBIT | PATENT OWNER |
Bingham & Ruffing, Rheumatoid Arthritis Treatment | Oct 28, 2016 | EXHIBIT | PATENT OWNER |
ClinicalTrials.gov identifier NCT00090129 | Oct 28, 2016 | EXHIBIT | PATENT OWNER |
Tishler, ANN. RHEUM. DIS. (1992) | Oct 28, 2016 | EXHIBIT | PATENT OWNER |
ClinicalTrials.gov identifier NCT00406419 | Oct 28, 2016 | EXHIBIT | PATENT OWNER |
ClinicalTrials.gov identifier NCT00476996 | Oct 28, 2016 | EXHIBIT | PATENT OWNER |
Rau et al. (2000) (Original German) (High-resolution) | Oct 28, 2016 | EXHIBIT | PATENT OWNER |
Christen, HUMAN IMMUNOLOGY (1999) | Oct 28, 2016 | EXHIBIT | PATENT OWNER |
Casadevall, NEPHROL. DIAL. TRANSPLANT. (2003) | Oct 28, 2016 | EXHIBIT | PATENT OWNER |
Smolen, ANN. RHEUM. DIS. (2015) | Oct 28, 2016 | EXHIBIT | PATENT OWNER |
Curriculum Vitae of Dr. Brian E. Harvey | Oct 28, 2016 | EXHIBIT | PATENT OWNER |
Nestorov, J. RHEUMATOL. (2005) | Oct 28, 2016 | EXHIBIT | PATENT OWNER |
Clowse, 2015 ACR/ARHP ANNUAL MEETING (2015) | Oct 28, 2016 | EXHIBIT | PATENT OWNER |
Guidance for Industry (Feb. 1999) | Oct 28, 2016 | EXHIBIT | PATENT OWNER |
Genovese, ARTHRITIS & RHEUM. (2008) | Oct 28, 2016 | EXHIBIT | PATENT OWNER |
Hamilton, CONTROLLED CLIN. TRIALS (2000) | Oct 28, 2016 | EXHIBIT | PATENT OWNER |
Statement of Janet Woodcock (May 2, 2007) | Oct 28, 2016 | EXHIBIT | PATENT OWNER |
Furst, ANN. RHEUM. DIS. (2008) | Oct 28, 2016 | EXHIBIT | PATENT OWNER |
Gibofsky, AM. J. MEDICINE (1997) | Oct 28, 2016 | EXHIBIT | PATENT OWNER |
Curriculum Vitae of Dr. Allan Gibofsky | Oct 28, 2016 | EXHIBIT | PATENT OWNER |
Ruffing & Bingham, Rheumatoid Arthritis Signs and Symptoms | Oct 28, 2016 | EXHIBIT | PATENT OWNER |
Mayo Clinic Staff, Rheumatoid arthritis | Oct 28, 2016 | EXHIBIT | PATENT OWNER |
Rheumatoid Arthritis: What is Rheumatoid Arthritis? | Oct 28, 2016 | EXHIBIT | PATENT OWNER |
Rankin, BR. J. RHEUMATOL. (1995) | Oct 28, 2016 | EXHIBIT | PATENT OWNER |
ClinicalTrials.gov identifier NCT00624351 | Oct 28, 2016 | EXHIBIT | PATENT OWNER |
Papp, CURRENT MED. RES. & OP. (2010) | Oct 28, 2016 | EXHIBIT | PATENT OWNER |
Rayes & Touma, DRUG DESIGN, DEVELOPMENT AND THERAPY (2014) | Oct 28, 2016 | EXHIBIT | PATENT OWNER |
Rigby, ARTHRITIS & RHEUM. (2012) | Oct 28, 2016 | EXHIBIT | PATENT OWNER |
Tak, ARTHRITIS & RHEUM. (2012) | Oct 28, 2016 | EXHIBIT | PATENT OWNER |
Torgerson, CONTROL. CLIN. TRIALS (2001) | Oct 28, 2016 | EXHIBIT | PATENT OWNER |
UnitedHealthcare 2015 Four-Tier Prescription Drug List (Jul. 2015) | Oct 28, 2016 | EXHIBIT | PATENT OWNER |
Exhibit M to Williams Declaration (Feb. 7, 2014) | Oct 28, 2016 | EXHIBIT | PATENT OWNER |
Curriculum Vitae of Dr. Jerry A. Hausman | Oct 28, 2016 | EXHIBIT | PATENT OWNER |
Summary Review of sBLA 125057/110 (Jan. 16, 2008) | Oct 28, 2016 | EXHIBIT | PATENT OWNER |
Approval Letter for BL 12057/89 (Feb. 27, 2007) | Oct 28, 2016 | EXHIBIT | PATENT OWNER |
Approval Letter for BL 125057/110 (Jan, 18, 2008) | Oct 28, 2016 | EXHIBIT | PATENT OWNER |
Approval Letter for sBLA 125057/114 (Feb. 21, 2008) | Oct 28, 2016 | EXHIBIT | PATENT OWNER |
Supplemental Approval Letter for BLA 125057/S-397 (June 30, 2016) | Oct 28, 2016 | EXHIBIT | PATENT OWNER |
ClinicalTrials.gov identifier NCT00785928 | Oct 28, 2016 | EXHIBIT | PATENT OWNER |
ClinicalTrials.gov identifier NCT01198002 | Oct 28, 2016 | EXHIBIT | PATENT OWNER |
ClinicalTrials.gov identifier NCT01261793 | Oct 28, 2016 | EXHIBIT | PATENT OWNER |
ClinicalTrials.gov identifier NCT01262365 | Oct 28, 2016 | EXHIBIT | PATENT OWNER |
Philippidis, Top 10 Clinical Trial Failures of 2013 (Feb. 3, 2014) | Oct 28, 2016 | EXHIBIT | PATENT OWNER |
Wallace, ANN. RHEUM. DIS. (2014) | Oct 28, 2016 | EXHIBIT | PATENT OWNER |
CVS-caremarkTM Performance Drug List (Oct. 2015) | Oct 28, 2016 | EXHIBIT | PATENT OWNER |
2015 Express Scripts Basic Formulary (Aug. 2014) | Oct 28, 2016 | EXHIBIT | PATENT OWNER |
Approval Letter for BL 125057/45 (Oct. 3, 2005) | Oct 28, 2016 | EXHIBIT | PATENT OWNER |
Supplemental Approval Letter for BLA 125057/232 (Sept. 28, 2012) | Oct 28, 2016 | EXHIBIT | PATENT OWNER |
Supplemental Approval Letter for BLA 125057/S-363 (Sept. 9, 2015) | Oct 28, 2016 | EXHIBIT | PATENT OWNER |
Certolizumab pegol/CIMZIA label (Nov. 18, 2009) | Oct 28, 2016 | EXHIBIT | PATENT OWNER |
Approval Letter for 99-0128 (Nov. 10, 1999) | Oct 28, 2016 | EXHIBIT | PATENT OWNER |
Golimumab/SIMPONI label (Apr. 2009) | Oct 28, 2016 | EXHIBIT | PATENT OWNER |
SEC Form 10-K for AbbVie Inc. (FY ended Dec. 31, 2015) | Oct 28, 2016 | EXHIBIT | PATENT OWNER |
Lisicki & Chu, POSTGRADUATE MEDICINE (2008) | Oct 28, 2016 | EXHIBIT | PATENT OWNER |
Greenapple, AM. HEALTH DRUG BENEFITS (2012) | Oct 28, 2016 | EXHIBIT | PATENT OWNER |
Williams & Edwards, RHEUMATOLOGY (2006) | Oct 28, 2016 | EXHIBIT | PATENT OWNER |
Navarro-Mill¿¿n, PLOS ONE (2016) | Oct 28, 2016 | EXHIBIT | PATENT OWNER |
Huynh, PATIENT PREFERENCES AND ADHERENCE (2014) | Oct 28, 2016 | EXHIBIT | PATENT OWNER |
SEC Form 10-K for Abbott Laboratories (FY ended Dec. 31, 2003) | Oct 28, 2016 | EXHIBIT | PATENT OWNER |
SEC Form 10-K for Abbott Laboratories (FY ended Dec. 31, 2005) | Oct 28, 2016 | EXHIBIT | PATENT OWNER |
Anantharaman, FROST & SULLIVAN (July 20, 2004) | Oct 28, 2016 | EXHIBIT | PATENT OWNER |
GlobalData, Top 50 pharmaceutical products by global sales | Oct 28, 2016 | EXHIBIT | PATENT OWNER |
Palmer, Top 10 rheumatoid arthritis drugs 2013 | Oct 28, 2016 | EXHIBIT | PATENT OWNER |
Berndt (1997) | Oct 28, 2016 | EXHIBIT | PATENT OWNER |
U.S. FDA, How Drugs are Developed and Approved | Oct 28, 2016 | EXHIBIT | PATENT OWNER |
Approval Letter for BL 103795/5110 (Oct. 17, 2003) | Oct 28, 2016 | EXHIBIT | PATENT OWNER |
Chilton & Collett, MUSCULOSKELET. CARE (2008) | Oct 28, 2016 | EXHIBIT | PATENT OWNER |
Louder, AM. HEALTH DRUG BENEFITS (2016) | Oct 28, 2016 | EXHIBIT | PATENT OWNER |
Curtis, & Singh, CLIN. THER. (2011) | Oct 28, 2016 | EXHIBIT | PATENT OWNER |
Sylwestrzak, AM. HEALTH DRUG BENEFITS (2014) | Oct 28, 2016 | EXHIBIT | PATENT OWNER |
Philippidis, Top 10 Clinical Trial Failures of 2012 (Feb. 5, 2013) | Oct 28, 2016 | EXHIBIT | PATENT OWNER |
Philippidis, Top 10 Clinical Trial Failures of 2014 (Feb. 9, 2015) | Oct 28, 2016 | EXHIBIT | PATENT OWNER |
Emery, PLOS ONE (2014) | Oct 28, 2016 | EXHIBIT | PATENT OWNER |
ClinicalTrials.gov identifier NCT00485589 | Oct 28, 2016 | EXHIBIT | PATENT OWNER |
ClinicalTrials.gov identifier NCT00673920 | Oct 28, 2016 | EXHIBIT | PATENT OWNER |
UCB Pharma Press Release (Jul. 28, 2015) | Oct 28, 2016 | EXHIBIT | PATENT OWNER |
Standing Protective Order | Oct 28, 2016 | EXHIBIT | PATENT OWNER |
Abbott, Introducing More Reasons Than Ever To Choose Humira | Oct 28, 2016 | EXHIBIT | PATENT OWNER |
Abbott Labs., Helping Your RA Patients Live More Normal Lives | Oct 28, 2016 | EXHIBIT | PATENT OWNER |
Supplemental Approval Letter for BLA 125057/356 (Sept. 23, 2014) | Oct 28, 2016 | EXHIBIT | PATENT OWNER |
D¿¿rner, ARTHRITIS RESEARCH THERAPY (2006) | Oct 28, 2016 | EXHIBIT | PATENT OWNER |
ClinicalTrials.gov identifier NCT02720120 | Oct 28, 2016 | EXHIBIT | PATENT OWNER |
Wallace, ARTHRITIS CARE & RES. (2016) | Oct 28, 2016 | EXHIBIT | PATENT OWNER |
RA Market Data (Oct. 25, 2016) (PROTECTIVE ORDER MATERIAL) | Oct 28, 2016 | EXHIBIT | PATENT OWNER |
Notice of Deposition of Michael Weisman, M.D. | Sep 21, 2016 | PAPER | PATENT OWNER |
Patent Owner's Power of Attorney | Sep 21, 2016 | PAPER | PATENT OWNER |
Patent Owner's Second Updated Mandatory Notices | Sep 21, 2016 | PAPER | PATENT OWNER |
ORDER Patent Owner's Motions for Pro Hac Vice Admission | Sep 19, 2016 | PAPER | BOARD |
Notice of Deposition of William J. Jusko, Ph.D. | Sep 16, 2016 | PAPER | PATENT OWNER |
Notice of Joint Stipulation to Modify Due Date 1 | Sep 16, 2016 | PAPER | PATENT OWNER |
Petitioner's Updated Mandatory Notices | Sep 15, 2016 | PAPER | PETITIONER |
Notice of Joint Stipulation to Modify Due Dates 1 and 2 | Aug 15, 2016 | PAPER | PATENT OWNER |
Patent Owner's Motion for Admission Pro Hac Vice of William G. McElwain | Jul 25, 2016 | PAPER | PATENT OWNER |
Patent Owner's Updated Exhibit List | Jul 25, 2016 | PAPER | PATENT OWNER |
Patent Owner's Motion for Admission Pro Hac Vice of Amy K. Wigmore | Jul 25, 2016 | PAPER | PATENT OWNER |
Declaration of William G. McElwain | Jul 25, 2016 | EXHIBIT | PATENT OWNER |
Declaration of Amy K. Wigmore | Jul 25, 2016 | EXHIBIT | PATENT OWNER |
Patent Owner's Objections To Evidence | Jul 21, 2016 | PAPER | PATENT OWNER |
Petitioner's Objections to Patent Owner's Exhibits | Jul 21, 2016 | PAPER | PETITIONER |
Decision to Institute Inter Partes Review | Jul 7, 2016 | PAPER | BOARD |
Scheduling Order | Jul 7, 2016 | PAPER | BOARD |
Patent Owner's Updated Mandatory Notices | Jun 30, 2016 | PAPER | PATENT OWNER |
Patent Owner's Preliminary Response | Apr 8, 2016 | PAPER | PATENT OWNER |
Exhibit 2001 - Declaration of Janet Pope | Apr 8, 2016 | EXHIBIT | PATENT OWNER |
Exhibit 2002 - Declaration of Michael E. Weinblatt | Apr 8, 2016 | EXHIBIT | PATENT OWNER |
Exhibit 2003 - Declaration of Diane R. Mould | Apr 8, 2016 | EXHIBIT | PATENT OWNER |
Exhibit 2004 - Declaration of Mr. Medgar Williams | Apr 8, 2016 | EXHIBIT | PATENT OWNER |
Exhibit 2005 - Kupper I Declaration | Apr 8, 2016 | EXHIBIT | PATENT OWNER |
Exhibit 2006 - Kupper II Declaration | Apr 8, 2016 | EXHIBIT | PATENT OWNER |
Exhibit 2007 - Rituximab/RITUXIN label | Apr 8, 2016 | EXHIBIT | PATENT OWNER |
Exhibit 2008 - Trastuzumab/HERCEPTIN label | Apr 8, 2016 | EXHIBIT | PATENT OWNER |
Exhibit 2009 - Abciximab/REOPRO label | Apr 8, 2016 | EXHIBIT | PATENT OWNER |
Exhibit 2010 - Daclizumab/ZENAPAX label | Apr 8, 2016 | EXHIBIT | PATENT OWNER |
Exhibit 2011 - Basiliximab/SIMULECT label | Apr 8, 2016 | EXHIBIT | PATENT OWNER |
Exhibit 2012 - Palivizumab/SYNAGIS label | Apr 8, 2016 | EXHIBIT | PATENT OWNER |
Exhibit 2013 - Gemtuzumab/MYLOTARG label | Apr 8, 2016 | EXHIBIT | PATENT OWNER |
Exhibit 2014 - Alemtuzumab/CAMPATH label | Apr 8, 2016 | EXHIBIT | PATENT OWNER |
Exhibit 2015 - Adalimumab M10-261 Clinical Study Report | Apr 8, 2016 | EXHIBIT | PATENT OWNER |
Exhibit 2016 - RESERVED | Apr 8, 2016 | EXHIBIT | PATENT OWNER |
Exhibit 2017 - Rowland and Tozer (3d ed. 1995) | Apr 8, 2016 | EXHIBIT | PATENT OWNER |
Exhibit 2018 - Porter and Charman (2000) | Apr 8, 2016 | EXHIBIT | PATENT OWNER |
Exhibit 2019 - Rau 1999 (original German) | Apr 8, 2016 | EXHIBIT | PATENT OWNER |
Exhibit 2020 - Rau 1999 (certified English translation) | Apr 8, 2016 | EXHIBIT | PATENT OWNER |
Exhibit 2021 - RESERVED | Apr 8, 2016 | EXHIBIT | PATENT OWNER |
Exhibit 2022 - Vincent, et al. (2013) | Apr 8, 2016 | EXHIBIT | PATENT OWNER |
Exhibit 2023 - van Schouwenburg, et al. (2013) | Apr 8, 2016 | EXHIBIT | PATENT OWNER |
Exhibit 2024 - Maini, et al. (1998) | Apr 8, 2016 | EXHIBIT | PATENT OWNER |
Exhibit 2025 - Wolfe, et al. (2001) | Apr 8, 2016 | EXHIBIT | PATENT OWNER |
Exhibit 2026 - Mason, et al. (2002) | Apr 8, 2016 | EXHIBIT | PATENT OWNER |
Exhibit 2027 - An (2010) | Apr 8, 2016 | EXHIBIT | PATENT OWNER |
Exhibit 2028 - Bross, et al. (Jun. 2001) | Apr 8, 2016 | EXHIBIT | PATENT OWNER |
Exhibit 2029 - Infliximab/REMICADE label | Apr 8, 2016 | EXHIBIT | PATENT OWNER |
Exhibit 2030 - Furst, et al. (Apr. 2001) | Apr 8, 2016 | EXHIBIT | PATENT OWNER |
Exhibit 2031 - Timmerman (Apr. 16, 2012) | Apr 8, 2016 | EXHIBIT | PATENT OWNER |
Exhibit 2032 - RESERVED | Apr 8, 2016 | EXHIBIT | PATENT OWNER |
Exhibit 2033 - Coherus IPR Petition | Apr 8, 2016 | EXHIBIT | PATENT OWNER |
Exhibit 2034 - Moreland, et al. (2000) | Apr 8, 2016 | EXHIBIT | PATENT OWNER |
Exhibit 2035 - Kavanaugh, et al. (2003) | Apr 8, 2016 | EXHIBIT | PATENT OWNER |
Exhibit 2036 - Radwanski, et al. (1998) | Apr 8, 2016 | EXHIBIT | PATENT OWNER |
Exhibit 2037 - Jusko (1980) | Apr 8, 2016 | EXHIBIT | PATENT OWNER |
Exhibit 2038 - Furst, et al. (May 2003) | Apr 8, 2016 | EXHIBIT | PATENT OWNER |
Exhibit 2039 - Rau, et al. (2000) (original German) | Apr 8, 2016 | EXHIBIT | PATENT OWNER |
Exhibit 2040 - Rau, et al. (2000) (certified English translation) | Apr 8, 2016 | EXHIBIT | PATENT OWNER |
Exhibit 2041 - van de Putte, et al. (2003) | Apr 8, 2016 | EXHIBIT | PATENT OWNER |
Exhibit 2042 - Rau, et al. F20 (1999) (original German) | Apr 8, 2016 | EXHIBIT | PATENT OWNER |
Exhibit 2043 - Rau, et al. F20 (1999) (certified English translation) | Apr 8, 2016 | EXHIBIT | PATENT OWNER |
Power of Attorney | Jan 15, 2016 | PAPER | INDICATES ARTIFACT WAS SUBMITTED ON BEHALF OF POTENTIAL_PATENT OWNER. |
Related Matters | Jan 15, 2016 | PAPER | INDICATES ARTIFACT WAS SUBMITTED ON BEHALF OF POTENTIAL_PATENT OWNER. |
Notice of Filing Date Accorded | Jan 8, 2016 | PAPER | BOARD |
Power of Attorney | Dec 29, 2015 | PAPER | PETITIONER |
Power of Attorney | Dec 29, 2015 | PAPER | PETITIONER |
Petition for Inter Partes Review of U.S. Patent No. 8,889,135 | Dec 29, 2015 | PAPER | PETITIONER |
U.S. Patent No. 8,889,135 | Dec 29, 2015 | EXHIBIT | PETITIONER |
Prosecution History of the '135 patent (excerpts) - PART 1 of 4 | Dec 29, 2015 | EXHIBIT | PETITIONER |
Prosecution History of the '135 patent (excerpts) - PART 2 of 4 | Dec 29, 2015 | EXHIBIT | PETITIONER |
Prosecution History of the '135 patent (excerpts) - PART 3 of 4 | Dec 29, 2015 | EXHIBIT | PETITIONER |
Prosecution History of the '135 patent (excerpts) - PART 4 of 4 | Dec 29, 2015 | EXHIBIT | PETITIONER |
Declaration of Michael H. Weisman, M.D. | Dec 29, 2015 | EXHIBIT | PETITIONER |
Declaration of Dr. William J. Jusko, Ph.D. | Dec 29, 2015 | EXHIBIT | PETITIONER |
van de Putte 1998 | Dec 29, 2015 | EXHIBIT | PETITIONER |
Rau 1998 | Dec 29, 2015 | EXHIBIT | PETITIONER |
Schattenkirchner 1998 | Dec 29, 2015 | EXHIBIT | PETITIONER |
van de Putte 1999 | Dec 29, 2015 | EXHIBIT | PETITIONER |
RESERVED | Dec 29, 2015 | EXHIBIT | PETITIONER |
RESERVED | Dec 29, 2015 | EXHIBIT | PETITIONER |
Kempeni 1999 | Dec 29, 2015 | EXHIBIT | PETITIONER |
RESERVED | Dec 29, 2015 | EXHIBIT | PETITIONER |
RESERVED | Dec 29, 2015 | EXHIBIT | PETITIONER |
Weisman (2000) | Dec 29, 2015 | EXHIBIT | PETITIONER |
REMICADE Summary Basis of Approval (1998) | Dec 29, 2015 | EXHIBIT | PETITIONER |
AbbVie's Clinical Review of Abbott's Biologic Licensing Application for adalimumab for the Treatment of RA, (Part 5) | Dec 29, 2015 | EXHIBIT | PETITIONER |
FDA's Clinical Review of Abbott's Biologic Licensing Application for adalimumab for the Treatment of RA | Dec 29, 2015 | EXHIBIT | PETITIONER |
European Medicines Agency, Scientific Discussion (2004) | Dec 29, 2015 | EXHIBIT | PETITIONER |
FDA Clinical Pharmacology and Biopharmaceutics Review | Dec 29, 2015 | EXHIBIT | PETITIONER |
van de Putte 2004 | Dec 29, 2015 | EXHIBIT | PETITIONER |
Keystone 2004 | Dec 29, 2015 | EXHIBIT | PETITIONER |
Clinical Development Programs for Drugs, Devices and Biological Products for the Treatment of Rheumatoid Arthritis (1999) | Dec 29, 2015 | EXHIBIT | PETITIONER |
Applicant's Remarks/Arguments in Response to Oppositions to European Patent 1406656B (Dec. 22, 2014) | Dec 29, 2015 | EXHIBIT | PETITIONER |
HUMIRA Product Label | Dec 29, 2015 | EXHIBIT | PETITIONER |
U.S. Patent No. 6,090,382 to Salfeld at al. | Dec 29, 2015 | EXHIBIT | PETITIONER |
U.S. Provisional Patent Application No. 60/296,961 | Dec 29, 2015 | EXHIBIT | PETITIONER |
Shargel 1999 | Dec 29, 2015 | EXHIBIT | PETITIONER |
Hanauer 1999 | Dec 29, 2015 | EXHIBIT | PETITIONER |
Kempeni 2000 | Dec 29, 2015 | EXHIBIT | PETITIONER |